Setrusumab (Anti-SOST / Sclerostin)

Setrusumab (Anti-SOST / Sclerostin) is a fully humanized monoclonal antibody directed against sclerostin. Setrusumab effectively improves bone strength and has the potential to be used in the research of Osteogenesis Imperfecta (OI). MW :143.44 kD.

• Supplier: Selleck Chemicals
• Product #: A2690
• Sku #: A2690-1mg*25